Lawsuit accuses Boehringer Ingelheim of false patent listings
A lawsuit filed in federal court in Connecticut accuses Boehringer Ingelheim Pharmaceuticals Inc. of manipulating the U.S. patent and drug approval system to “exclude generic competitors” and monopolize the market. The lawsuit, first reported by law.com, …